BBVA USA Bancshares’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $2.04M | Sell |
32,326
-1,847
| -5% | -$115K | 0.1% | 202 |
|
|
2020
Q4 | $2.12M | Sell |
34,173
-1,470
| -4% | -$90.4K | 0.11% | 176 |
|
|
2020
Q3 | $2.15M | Sell |
35,643
-983
| -3% | -$59.2K | 0.12% | 159 |
|
|
2020
Q2 | $2.15M | Buy |
36,626
+5,663
| +18% | +$339K | 0.13% | 154 |
|
|
2020
Q1 | $1.73M | Buy |
30,963
+1,801
| +6% | +$110K | 0.12% | 156 |
|
|
2019
Q4 | $1.87M | Buy |
29,162
+13,225
| +83% | +$757K | 0.11% | 176 |
|
|
2019
Q3 | $808K | Buy |
15,937
+2,153
| +16% | +$101K | 0.05% | 258 |
|
|
2019
Q2 | $625K | Buy |
13,784
+1,526
| +12% | +$71.1K | 0.04% | 335 |
|
|
2019
Q1 | $585K | Sell |
12,258
-1,272
| -9% | -$63.4K | 0.04% | 337 |
|
|
2018
Q4 | $704K | Sell |
13,530
-92
| -0.7% | -$4.94K | 0.05% | 285 |
|
|
2018
Q3 | $846K | Buy |
13,622
+2,871
| +27% | +$170K | 0.05% | 289 |
|
|
2018
Q2 | $595K | Sell |
10,751
-927
| -8% | -$50.1K | 0.04% | 339 |
|
|
2018
Q1 | $739K | Sell |
11,678
-826
| -7% | -$53.1K | 0.05% | 308 |
|
|
2017
Q4 | $766K | Sell |
12,504
-1,540
| -11% | -$96.3K | 0.05% | 313 |
|
|
2017
Q3 | $895K | Sell |
14,044
-24,702
| -64% | -$1.44M | 0.06% | 290 |
|
|
2017
Q2 | $2.16M | Sell |
38,746
-9,026
| -19% | -$491K | 0.14% | 152 |
|
|
2017
Q1 | $2.6M | Buy |
47,772
+711
| +2% | +$39K | 0.17% | 130 |
|
|
2016
Q4 | $2.75M | Buy |
47,061
+2,827
| +6% | +$155K | 0.19% | 122 |
|
|
2016
Q3 | $2.38M | Buy |
44,234
+945
| +2% | +$60.7K | 0.17% | 127 |
|
|
2016
Q2 | $3.18M | Sell |
43,289
-603
| -1% | -$42.6K | 0.24% | 104 |
|
|
2016
Q1 | $2.8M | Sell |
43,892
-1,397
| -3% | -$88.1K | 0.21% | 106 |
|
|
2015
Q4 | $3.12M | Sell |
45,289
-236
| -0.5% | -$15.6K | 0.23% | 108 |
|
|
2015
Q3 | $2.69M | Buy |
45,525
+31
| +0.1% | +$1.97K | 0.21% | 112 |
|
|
2015
Q2 | $3.03M | Buy |
45,494
+838
| +2% | +$55.2K | 0.17% | 138 |
|
|
2015
Q1 | $2.88M | Buy |
44,656
+1,896
| +4% | +$119K | 0.13% | 171 |
|
|
2014
Q4 | $2.52M | Sell |
42,760
-5,023
| -11% | -$283K | 0.11% | 173 |
|
|
2014
Q3 | $2.45M | Sell |
47,783
-225
| -0.5% | -$11.2K | 0.11% | 176 |
|
|
2014
Q2 | $2.33M | Sell |
48,008
-2,507
| -5% | -$124K | 0.1% | 194 |
|
|
2014
Q1 | $2.62M | Sell |
50,515
-445
| -0.9% | -$23.7K | 0.12% | 180 |
|
|
2013
Q4 | $2.71M | Buy |
50,960
+1,430
| +3% | +$72.8K | 0.12% | 177 |
|
|
2013
Q3 | $2.29M | Sell |
49,530
-9,379
| -16% | -$412K | 0.11% | 186 |
|
|
2013
Q2 | $2.63M | Buy |
+58,909
| New | +$2.56M | 0.13% | 173 |
|
Other funds holding BMY
BBVA USA Bancshares's BMY Position: Q1 2021 in Review
BBVA USA Bancshares reduced its Bristol-Myers Squibb (BMY) stake by 5.4% in Q1 2021, selling an estimated $115K and leaving 32,326 shares worth $2.04M. The position accounts for 0.1% of the portfolio, ranked #202.
BBVA USA Bancshares first reported a position in BMY in Q2 2013 and has held it in 32 quarters since. The position peaked at $3.18M in Q2 2016. 2,369 funds tracked by Wall St. Rank hold BMY as of Q1 2021.
- BBVA USA Bancshares held 32,326 shares of Bristol-Myers Squibb worth $2.04M as of Q1 2021.
- BBVA USA Bancshares sold 1,847 Bristol-Myers Squibb shares in Q1 2021, an estimated $115K.
- Bristol-Myers Squibb made up 0.1% of BBVA USA Bancshares's portfolio in Q1 2021, its #202 holding.
- BBVA USA Bancshares first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 32 quarters since.
- BBVA USA Bancshares's Bristol-Myers Squibb position peaked at $3.18M in Q2 2016.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.
Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.